Efficacy of a Low Dose of Pitavastatin Compared with Atorvastatin in Primary Hyperlipidemia: Results of a 12-week, open label study
Author:
Affiliation:
1. Miyauchi Makoto Memorial Clinic, Shizuoka, Japan.
2. Ishii Medical Clinic, Shizuoka, Japan.
3. Kaneki Medical Clinic, Shizuoka, Japan.
4. Tsujibayashi Medical Clinic, Shizuoka, Japan.
5. Sakurai Medical Clinic, Shizuoka, Japan.
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/jat/13/2/13_2_108/_pdf
Reference30 articles.
1. 1) Suzuki H, Aoki T, Tamaki T, Sato F, Kitahara M, and Saito Y: Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs. Atherosclerosis, 1999; 146:259-270.
2. 2) Fujino H, Saito T, Tsunenari Y, and Kojima J: Interaction between several medicines and statins. Arzneimittelforschung, 2003; 53:145-153.
3. 3) Fujino H, Yamada I, Shimada S, Yoneda M, and Kojima J: Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: Hyman UDP-glucuronosyltransferase enzymes involved in lactonization. Xenobiotica, 2003; 33:27- 41.
4. 4) Yamasaki H, Fujino H, Kanazawa M, Tamaki T, Sato F, Suzuki M, and Kitahara M: Pharmacological and pharmacokinetic features and clinical effects of pitavastatin. Folia Pharmacol Jpn, 2004; 123:349-362.
5. 5) Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ, Jones PH, Haber HE, and Black DM: Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol, 1995; 15:678-682.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas;Journal of Diabetes Investigation;2020-12-30
2. Pitavastatin for lowering lipids;Cochrane Database of Systematic Reviews;2020-06-19
3. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan;Atherosclerosis;2016-08
4. Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin;Atherosclerosis Supplements;2015-01
5. Pitavastatin;Drugs;2012-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3